• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病患者冠状动脉血运重建术后性别与心血管结局的关联。

The association of gender to cardiovascular outcomes after coronary artery revascularization in patients with end-stage renal disease.

作者信息

Krishnaswami Ashok, Chang Tara I, Jang James J, Leong Thomas K, Go Alan S

机构信息

Division of Cardiology, Kaiser Permanente San Jose Medical Center, San Jose, California.

出版信息

Clin Cardiol. 2014 Sep;37(9):546-51. doi: 10.1002/clc.22306. Epub 2014 Jun 30.

DOI:10.1002/clc.22306
PMID:24980833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6649527/
Abstract

BACKGROUND

Inadequate recruitment of women and an exclusion of patients with end-stage renal disease (ESRD) in coronary revascularization trials have led to knowledge gaps of gender-based outcomes.

HYPOTHESIS

Women have equivalent cardiovascular outcomes when compared to men.

METHODS

We conducted a retrospective observational study utilizing Kaiser Permanente Northern California (KPNC) databases and identified 1015 adults with ESRD who underwent coronary revascularization between 1996 and 2008. We ascertained baseline characteristics, primary (mortality at 5 years) and secondary (myocardial infarction [MI] and repeat revascularization) outcomes from KPNC databases, state death certificates, and Social Security Administration files. A multivariable logistic regression was used to determine the association of gender to the prespecified outcomes.

RESULTS

Men and women were similar in age (P = 0.23). The mean number of baseline comorbidities was higher in women (2.7, 95% confidence interval [CI]: 2.5-2.9) compared to men (2.3, 95% CI: 2.1-2.4, P = 0.0002). The risk-adjusted odds ratios (OR) of female gender to death at 5 years (OR: 1.12, 95% CI: 0.83-1.52), MI (OR: 1.19, 95% CI: 0.86-1.64), and repeat revascularization (OR: 1.01, 95% CI: 0.70-1.45) were similar to men. Age modified the effect of gender for the primary outcome death (Pinteraction < 0.048), with a trend toward worse outcomes in younger women and improved outcomes in older women. This effect was noted more in patients who underwent coronary artery bypass grafting.

CONCLUSIONS

Although the overall relative risk of cardiovascular outcomes after coronary revascularization in ESRD was equivalent between men and women, age had a significant interaction with gender on overall mortality.

摘要

背景

在冠状动脉血运重建试验中,女性招募不足以及终末期肾病(ESRD)患者被排除在外,导致了基于性别的结局方面的知识空白。

假设

与男性相比,女性具有同等的心血管结局。

方法

我们利用北加利福尼亚州凯撒医疗集团(KPNC)数据库进行了一项回顾性观察研究,确定了1996年至2008年间接受冠状动脉血运重建的1015例ESRD成年患者。我们从KPNC数据库、州死亡证明和社会保障管理档案中确定了基线特征、主要结局(5年死亡率)和次要结局(心肌梗死[MI]和再次血运重建)。使用多变量逻辑回归来确定性别与预先指定结局之间的关联。

结果

男性和女性年龄相似(P = 0.23)。女性的基线合并症平均数量(2.7,95%置信区间[CI]:2.5 - 2.9)高于男性(2.3,95%CI:2.1 - 2.4,P = 0.0002)。女性在5年时死亡(OR:1.12,95%CI:0.83 - 1.52)、MI(OR:1.19,95%CI:0.86 - 1.64)和再次血运重建(OR:1.01,95%CI:0.70 - 1.45)的风险调整比值比与男性相似。年龄改变了性别对主要结局死亡的影响(P交互作用<0.048),年轻女性结局有变差趋势,老年女性结局有改善趋势。这种效应在接受冠状动脉旁路移植术的患者中更明显。

结论

尽管ESRD患者冠状动脉血运重建后心血管结局的总体相对风险在男性和女性中相当,但年龄在总体死亡率上与性别有显著交互作用。

相似文献

1
The association of gender to cardiovascular outcomes after coronary artery revascularization in patients with end-stage renal disease.终末期肾病患者冠状动脉血运重建术后性别与心血管结局的关联。
Clin Cardiol. 2014 Sep;37(9):546-51. doi: 10.1002/clc.22306. Epub 2014 Jun 30.
2
Coronary artery bypass grafting and percutaneous coronary intervention in patients with end-stage renal disease.终末期肾病患者的冠状动脉旁路移植术和经皮冠状动脉介入治疗
Eur J Cardiothorac Surg. 2015 May;47(5):e193-8. doi: 10.1093/ejcts/ezv104.
3
Coronary artery bypass graft type and outcomes in maintenance dialysis.维持性透析患者的冠状动脉旁路移植术类型及预后
J Cardiovasc Surg (Torino). 2015 Jun;56(3):463-71. Epub 2013 Dec 17.
4
Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.稳定型冠状动脉疾病中的缺血改变是死亡和心肌梗死的独立预测因子。
JACC Cardiovasc Imaging. 2012 Jul;5(7):715-24. doi: 10.1016/j.jcmg.2012.01.019.
5
Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.肾功能不全严重程度对行经皮冠状动脉介入治疗患者住院死亡率相关因素的影响。
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.
6
Revascularization options in patients with chronic kidney disease.慢性肾病患者的血运重建选择
Tex Heart Inst J. 2010;37(1):9-18.
7
Temporal trends in mortality after coronary artery revascularization in patients with end-stage renal disease.终末期肾病患者冠状动脉血运重建术后死亡率的时间趋势。
Perm J. 2014 Summer;18(3):11-6. doi: 10.7812/TPP/14-003.
8
Comparative Outcomes of Carotid Artery Stent Placement and Carotid Endarterectomy in Patients with Chronic Kidney Disease and End-Stage Renal Disease.慢性肾脏病和终末期肾病患者行颈动脉支架置入术与颈动脉内膜切除术的比较结果
J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1721-1727. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.040. Epub 2016 Apr 13.
9
Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.慢性肾脏病对接受冠状动脉旁路移植术或药物洗脱支架治疗的无保护左主干冠状动脉疾病患者的影响。
Coron Artery Dis. 2016 Nov;27(7):535-42. doi: 10.1097/MCA.0000000000000396.
10
Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.多支冠状动脉疾病合并慢性肾脏病患者的血运重建:依维莫司洗脱支架与冠状动脉旁路移植术的比较
J Am Coll Cardiol. 2015 Sep 15;66(11):1209-1220. doi: 10.1016/j.jacc.2015.06.1334.

引用本文的文献

1
Gender-related mortality and in-hospital complications following ST-segment elevation myocardial infarction: data from a primary percutaneous coronary intervention cohort.ST段抬高型心肌梗死后与性别相关的死亡率及院内并发症:来自直接经皮冠状动脉介入治疗队列的数据
Clin Cardiol. 2015 Mar;38(3):145-9. doi: 10.1002/clc.22363. Epub 2015 Feb 27.

本文引用的文献

1
Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States.美国经皮冠状动脉血运重建术和药物洗脱支架与裸金属支架治疗后透析患者的长期生存和重复冠状动脉血运重建
Circulation. 2013 May 7;127(18):1861-9. doi: 10.1161/CIRCULATIONAHA.112.001264. Epub 2013 Apr 9.
2
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.终末期肾病患者的多支冠状动脉旁路移植术与经皮冠状动脉介入治疗。
J Am Soc Nephrol. 2012 Dec;23(12):2042-9. doi: 10.1681/ASN.2012060554.
3
Strategies for multivessel revascularization in patients with diabetes.多血管血运重建策略在糖尿病患者中的应用。
N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.
4
Cardiovascular disease in women.女性心血管疾病。
Curr Probl Cardiol. 2012 Nov;37(11):450-526. doi: 10.1016/j.cpcardiol.2012.07.001.
5
Coronary revascularization in women.女性冠状动脉血运重建。
Clin Cardiol. 2012 Mar;35(3):156-9. doi: 10.1002/clc.21976.
6
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会冠状动脉旁路移植手术指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 6;124(23):2610-42. doi: 10.1161/CIR.0b013e31823b5fee. Epub 2011 Nov 7.
7
The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).在当代,对接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者进行的性别与结局的相关性分析:来自密歇根蓝十字蓝盾心血管联合会(BMC2)的见解。
Am Heart J. 2011 Jan;161(1):106-112.e1. doi: 10.1016/j.ahj.2010.09.030.
8
Population trends in the incidence and outcomes of acute myocardial infarction.人口趋势对急性心肌梗死发病率和结局的影响。
N Engl J Med. 2010 Jun 10;362(23):2155-65. doi: 10.1056/NEJMoa0908610.
9
Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry.当代经皮冠状动脉介入治疗后不良结局的性别差异:来自密歇根蓝十字蓝盾心血管联盟(BMC2)经皮冠状动脉介入治疗登记处的分析。
Am Heart J. 2010 Apr;159(4):677-683.e1. doi: 10.1016/j.ahj.2009.12.040.
10
A randomized trial of therapies for type 2 diabetes and coronary artery disease.2型糖尿病与冠状动脉疾病治疗的随机试验
N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7.